LivingGLP1
Study S001874

Pilot 2: Glucagon-like Peptide-1 in Sleep Disordered Breathing

Registration

Registration
NCT01832532
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Phase
PHASE1; PHASE2
Masking
NONE
Status
COMPLETED
Enrollment
34
Start
2013-04
Primary completion
2015-12
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Conditions
Sleep Apnea; Sleep Disordered Breathing
Interventions
DRUG:liraglutide
Results posted
TRUE
Individual participant data sharing
UNDECIDED
Secondary identifiers
NIH:UL1RR026314

Registered primary outcomes

  • Change in Apnea Hypopnea Index (AHI) From Baseline [Baseline and 4 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.